Importance of laboratory parameters in the evaluation of Crohn's disease activity

Insights

A new laboratory index for Crohn's disease (CD) activity, the LCDAI, complements the clinical CDAI. It detects inflammation not evident clinically, especially in patients in remission, improving CD monitoring.

Area of Science:

  • Gastroenterology
  • Clinical Chemistry
  • Immunology

Background:

  • Crohn's disease (CD) management relies on assessing disease activity.
  • Existing clinical indices like the Crohn's Disease Activity Index (CDAI) may not capture all inflammatory activity.

Purpose of the Study:

  • To develop and validate a laboratory-based index for Crohn's disease activity (LCDAI).
  • To assess the relationship between the LCDAI and the conventional CDAI.
  • To identify subclinical inflammation in CD patients.

Main Methods:

  • 131 examinations from 63 CD patients were analyzed.
  • 10 laboratory investigations were performed at each visit.
  • A laboratory index (LCDAI) was developed using multiple regression analysis based on expert evaluation of lab results.
  • Correlation between LCDAI and CDAI was assessed.

Main Results:

  • C-reactive protein, ESR, and WBC count were key components of the LCDAI.
  • LCDAI correlated with CDAI in moderate to severe disease.
  • LCDAI indicated subclinical inflammation in 55% of patients in clinical remission.

Conclusions:

  • The LCDAI effectively reflects inflammatory activity in Crohn's disease.
  • Supplementing the clinical CDAI with the LCDAI provides a more comprehensive assessment of disease activity.
  • The LCDAI is valuable for detecting subclinical inflammation in CD patients.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...